|
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthese, or its employees that the report constitutes an admission that the product, depuy synthese, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
It was reported that during the surgery, when opened the primary packing, found that there was an "polyethylene component" which was never seen from other products with same product code (as showed in attached photo).The surgeon used this product to complete the surgery.The extra "polyethylene component" was discarded and not implanted into the patient.There were no adverse consequences to the patient till now.No additional information could be provided.
|
|
Product complaint # (b)(4).Investigation summary according to the information received, extra component.It was reported that during the surgery, when opened the primary packing, found that there was an "polyethylene component" which was never seen from other products with same product code (as showed in attached photo).The surgeon used this product to complete the surgery.The extra "polyethylene component" was discarded and not implanted into the patient.There were no adverse consequences to the patient till now.No additional information could be provided.The product was not returned to depuy synthes, however photos were provided for review.See attachment (b)(4).The photo investigation revealed that the attune ps fem lt sz 5 cem is observed with a piece of plastic inside an open box, where a previous manipulation is observed, the device observed belongs to an attune implant; however, inside the box a plastic piece is observed, and this piece can be found in a sigma implants.This indicates manipulation of the implants, therefore, it cannot be confirmed that there was a foreign substance inside the box prior to its manipulation.Based on the current manufacturing investigation which has been completed, the following was concluded: the complaint is non-verifiable the complaint occurrence rate for the review period between 14-august-2022 to 14-february-2024 was (b)(4).Since the device was not returned, a dimensional inspection cannot be performed.The overall complaint was unconfirmed as the observed condition of the attune ps fem lt sz 5 cem would not contribute to the complained device issue.Based on the investigation findings, it has been determined that no corrective and/or preventative action is proposed.There is no indication that a design or manufacturing issue has caused the reported complaint condition.As part of depuy synthes quality process, all devices are manufactured, inspected, and released to approved specifications.Additional monitoring for any potential safety signals will be conducted through complaint trending and other post-market safety surveillance activities.Device history lot a review was completed of the dhr and operations management system for the following: product code 150410105, work order (b)(4) was manufactured on 12-mar-2023.All raw materials met specification.12 parts were manufactured to specification.Scrap: there was no scrap associated with this lot.There is 2 non-conformances associated with this lot.1.Nr-0199217 is related to a failed scheduled calibration of cig2016 elgameter medica 100.There is no correlation between this non-no conformance and the failure mode of the complaint.2.Nr-0205494 is related to reviewing data in the idcs system by a program lead that some work orders did not appear to have inspection information.There is no correlation between this non-conformance and the failure mode of the complaint.H10 additional narrative: added: b5.
|